European Archives - Page 1334 of 1425 - European Medical Journal

EMJ

Study Shows Prostate Cancer Screening under Age of 55 May be of Limited Value

Barcelona, 14 November 2015: Mass prostate cancer (PSA) screening before the age of 55 may not have any benefit over screening starting after…

Treating Inadequately Controlled Asthma: Exploring the Potential of Phenotype-Targeted Therapy

Asthma is inadequately treated with the current standard of care. This session aimed to explore the potential of a phenotype-targeted approach to…

Inhaler Devices: The past, the Present, and the Future

Inhaler handling errors negatively impact asthma control and represent one of the most common challenges in asthma management. Overcoming inhaler…

Therapy for Alpha-1 Antitrypsin Deficiency: The Evidence for Efficacy

Prof McElvaney opened the symposium with a brief overview of the disease history and available treatments to date for alpha-1 antitrypsin deficiency…

Advances in Ambulatory Oxygen Workshop and Long-Term Oxygen Therapy in Real-Life Practice

The practical workshop presented recent advances in the field of ambulatory oxygen (AO), with experts discussing identification of patients who would…

Long-Term NIV in COPD – Who and When?

Dr Wijkstra opened this symposium on long-term non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD). Dr…

Challenges of Inhaler Use in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease

The mainstay of the pharmacological management of asthma and chronic obstructive pulmonary disease (COPD) is the use of inhaled drugs. This route…

Positive Pressure Therapies Used in the Treatment of Postoperative Respiratory Failure – Evidence for Use and Future Directions

Although postoperative RF is usually multifactorial in origin, the development of atelectasis preoperatively is a significant contributory factor.

EMJ Respiratory 3.2 2015

Hello and a very warm welcome to this edition of European Medical Journal Respiratory, your comprehensive source for insights and developments in…

EMJ

Multiple Scientific Presentations at the Liver Meeting 2015 Further Highlight the Utility of Sofosbuvir-Based Hepatitis C Therapies

San Francisco, November 14, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it will present 32 scientific presentations related to its…